Cincor Pharma Inc (CINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -50,369 | -22,299 | N/A | N/A |
| Accounts receivable | N/A | 8 | N/A | N/A |
| Accounts payable and accrued liabilities | -3,115 | 2,812 | N/A | N/A |
| Other Working Capital | -871 | 3,677 | N/A | N/A |
| Other Operating Activity | 23,508 | -1,595 | 0 | 0 |
| Operating Cash Flow | $-30,847 | $-17,396 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 1,404 | N/A | N/A | N/A |
| Other Financing Activity | 139,971 | 31,990 | 0 | 0 |
| Financing Cash Flow | $141,375 | $31,990 | $N/A | $N/A |
| Beginning Cash Position | 26,078 | 11,484 | N/A | N/A |
| End Cash Position | 136,606 | 26,078 | N/A | N/A |
| Net Cash Flow | $110,528 | $14,594 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -30,847 | -17,396 | N/A | N/A |
| Free Cash Flow | -30,847 | -17,396 | 0 | 0 |